Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By https://allenayiw127004.look4blog.com/74285416/tirzepatide-a-promising-new-treatment-for-obesity